Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors
Sho Okamoto, Hiroshi Ureshino, Atsushi Kawaguchi, Motoaki Miyazono, Yuji Ikeda, Shinya Kimura
Topics & Concepts
DiscontinuationMedicineDasatinibNilotinibInternal medicineTyrosine-kinase inhibitorImatinibRenal functionMyeloid leukemiaAdverse effectTyrosine kinaseImatinib mesylateGastroenterologyOncologyPharmacologyCancerReceptorChronic Myeloid Leukemia TreatmentsEosinophilic Disorders and SyndromesMyeloproliferative Neoplasms: Diagnosis and Treatment